Clinical trial
A Randomized, Double Blind, Placebo Controlled Parallel Arm Clinical Study to Evaluate the Efficacy of LN18178 in Improving Muscle Strength, Aerobic Capacity and Body Composition in Healthy Young Males
NCT07092722 is registered in ClinicalTrials.gov with GENCOR Lifestage Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double Blind, Placebo Controlled Parallel Arm Clinical Study to Evaluate the Efficacy of LN18178 in Improving Muscle Strength, Aerobic Capacity and Body Composition in Healthy Young Males
- Lead sponsor
- GENCOR Lifestage Solutions
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 4, 2025
- Completion date
- January 15, 2026
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
endurance, healthy human volunteers, muscle strength recovery